TrialBlood cells, molecules & diseases2018

Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial.

Pierluigi Tricoci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.